GlassScriptPhysician profile
Jarielle Carter
NPI 1659926756
$6,822.16
in general payments reported to CMS, 2019-2025
47 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,575 · 2022: $1,708 · 2023: $1,847 · 2024: $1,384 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,444 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,443.97 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,243.42 | 2021-2025 | |
| Pfizer INC. | $590.62 | 2021-2025 | |
| Lilly USA, LLC | $525.93 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
| Janssen Pharmaceuticals, INC | $397.23 | 2021-2024 | Xarelto |
| Amgen INC. | $357.52 | 2021-2024 | Repatha, Otezla |
| Otsuka America Pharmaceutical, INC. | $357.34 | 2021-2024 | Rexulti |
| Novo Nordisk INC | $311.62 | 2021-2025 | Rybelsus, Ozempic |
| Vanda Pharmaceuticals INC. | $297.41 | 2021-2023 | Hetlioz |
| Biohaven Pharmaceutical Holding Company LTD. | $231.63 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $226.74 | 2021-2024 | Farxiga, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $193.01 | 2021-2024 | |
| Dexcom, INC. | $137.69 | 2021-2024 | Dexcom G6 Transmitter |
| Sk Life Science, INC. | $125.00 | 2023 | Xcopri |
| Glaxosmithkline, LLC. | $122.65 | 2021-2025 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $121.52 | 2021-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarielle Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.